the truth about DIET PILLS

Marinos, Sarah
April 2011
Good Health (Australia Edition);Apr2011, p62
The article explores the business of diet pills for losing weight. The Sibutramine Cardiovascular OUTcomes (SCOUT) study linked the reductil to 16 percent incidence of heart attack and stroke in obese patients. In 2011, approximately 4.2 per cent of the 789.6 million dollars weight-loss market will be made up of medicinal weight-loss products such as pills. Doctor Steve Hambleton suggests to have a healthy balanced diet, reducing the amount of consumed fat, and cutting back on portion sizes.


Related Articles

  • Antidote. Siegel, Marc // Medical Marketing & Media;Apr2006, Vol. 41 Issue 4, p14 

    The article examines some weight loss drugs in the United States. Xenical or Orlistat are drugs that hinder fat absorption into the gastrointestinal tract. An appetite suppressant, Meridia prevents the reabsorption of serotonin, a hormone in the brain that is released when a patient is full from...

  • sibutramine.  // Royal Society of Medicine: Medicines;2002, p495 

    The article presents information on the appetite suppressant sibutramine. This drug is used to aid weight loss in obesity treatment, maintain weight loss in the severely obese who are at risk from hypertension, diabetes mellitus, or disorders of fat metabolism. Most commonly people taking...

  • Health Canada issues warning against the use of Slim.  // Reactions Weekly;1/13/2007, Issue 1134, p3 

    This article reports that Health Canada warned consumers against the use of Slim, a weight-loss product manufactured in China. The warning comes after the health department of Hong Kong, China issued similar advice amongst concerns that the product is adulterated with sibutramine, a prescription...

  • FDA requests withdraw of sibutramine from US market.  // Cardiology Today;Dec2010, Vol. 13 Issue 12, p24 

    The article reports that a recommendation against the continued prescription and use of sibutramine has been issued by the U.S. Food and Drug Administration (FDA) in line with the elevated cardiovascular (CV) risks observed in some patients taking the drug.

  • Há irracionalidades no consumo de inibidores de apetite no Brasil? Uma análise farmacoeconométrica de dados em painel. Mota, Daniel Marques; de Oliveira, Márcia Gonçalves; Bovi, Rafael Filiacci; Silva, Sidarta Figueredo; Fernandes Cunha, Jeane Araújo; Divino, José Angelo // Revista Ciência & Saúde Coletiva;may2014, Vol. 19 Issue 5, p1389 

    The scope of this study is to analyze the determinants of the use of appetite suppressants (amfepramone, femproporex, mazindol and sibutramine) through the estimation of a dynamic panel dataset model for the Brazilian state capitals and the Federal District (DF) in the period from 2009 to 2011....

  • Sibutramine and weight maintenance.  // Caribbean Health;Jun2001, Vol. 4 Issue 3, p29 

    The article reports on the effectiveness of sibutramine drug on weight loss. The drug is a tertiary amine that promotes weight loss by decreasing food intake and by maintaining energy expenditure during weight loss. Study shows that the drug helps maintain the weight loss after an initial period...

  • Anti Obesity Drugs. Huppertz, Christine // Encyclopedic Reference of Molecular Pharmacology;2004, p97 

    The article presents an encyclopedia entry for the term "anti-obesity drugs," which are drugs that help to control appetite and reduce weight. It discusses the mechanism of action of anti-obesity drugs. It also provides information on the clinical use and side effects of these drugs. Several...

  • Under-18s access anti-obesity drug.  // Community Practitioner;Oct2009, Vol. 82 Issue 10, p8 

    The article cites a study which finds that anti-obesity drugs that are licensed for adult use only are being prescribed to people under 18 years of age in Great Britain. It adds that the prescriptions of drugs which include orlistat, sibutramine and rimonabant have risen 15-fold from 1999 to...

  • Why Diet Drugs Can Be Diet Dangers. Murphy, Dee // Current Health 2;Dec2000, Vol. 27 Issue 4, p18 

    Explains the dangers of using diet pills and other weight loss preparations. INSET: Why Diet Claims: Fact or Fiction?.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics